<PAGE>
/------------------------------/
/ OMB APPROVAL /
/------------------------------/
/ OMB Number: 3235-0287 /
/ Expires: Sept. 30, 1998 /
/ Estimated average burden /
/ hours per response...... 0.5 /
/------------------------------/
+--------+
| FORM 4 | U.S. SECURITIES AND EXCHANGE COMMISSION
+--------+ WASHINGTON, D.C. 20549
[X] Check this box if
no longer subject STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
to Section 16.
Form 4 or Form 5 Filed pursuant to Section 16(a) of the Securities
obligations may Exchange Act of 1934, Section 17(a) of the
continue. See Public Utility Holding Company Act of 1935 or
Instruction 1(b). Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
--------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
Knott David M.
--------------------------------------------------------------------------------
(Last) (First) (Middle)
485 Underhill Blvd., Suite 205
--------------------------------------------------------------------------------
(Street)
Syosset, NY 11791
--------------------------------------------------------------------------------
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol Columbia Laboratories, Inc. (COB)
-----------------------------------
3. I.R.S. Identification Number of Reporting Person, if an entity
(voluntary) ###-##-####
--------------
4. Statement for Month/Year June, 2000
---------------------------------------------------
5. If Amendment, Date of Original (Month/Year)
---------------------------------
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
___ Director ___ Officer ___ 10% Owner _X_ Other
(give title below) (specify below)
Former Member of a
------------------
group described on
------------------
page 2
------
----------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__X__ Form filed by More than One Reporting Person
Table I--Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------------------------------------
1. Title 2. Trans- 3. Trans- 4. Securities Acquired (A) 5. Amount of 6. Owner- 7. Nature
of action action or Disposed of (D) Securities ship of In-
Security Date Code (Instr. 3, 4 and 5) Beneficially Form: direct
(Instr. 3) (Month/ (Instr. 8) Owned at Direct Bene-
Day/ ----------------------------------------------- End of (D) or ficial
Year) Month Indirect Owner-
Code V Amount (A) or Price (Instr. 3 and 4) (I) ship
(D) (Instr. 4) (Instr. 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 6/15/00 P 18,100 A $5.41 I (1)(2)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 6/15/00 P 11,900 A $5.41 I (1)(2)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 778,800(3)
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly. SEC 1473 (7-96)Reminder: Report on a separate line
for each class of securities beneficially owned directly or indirectly.
(Print or Type Responses)
Page 1 of 3 pages
SEC 1474 (8/92)
<PAGE>
Table II--Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<TABLE>
<CAPTION>
-----------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative 2. Conver- 3. Trans- 4. Transac- 5. Number of Deriv-
Security (Instr. 3) sion or action tion Code ative Securities
Exercise Date (Instr. 8) Acquired (A) or
Price of (Month/ Disposed of (D)
Deriv- Day/ (Instr. 3, 4, and 5)
ative Year)
Security
---------------------------------------------------
Code V (A) (D)
-----------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
-----------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------
</TABLE>
Table II--Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------------------------------------
6. Date Exer- 7. Title and Amount of 8. Price 9. Number 10. Owner- 11. Na-
cisable and Underlying Securities of of Deriv- ship ture
Expiration (Instr. 3 and 4) Deriv- ative Form of In-
Date ative Secur- of De- direct
(Month/Day/ Secur- ities rivative Bene-
Year) ity Bene- Securities ficial
(Instr. ficially Bene- Owner-
-------------------------------------------- 5) Owned ficially ship
Date Expira- Amount or at End Owned at (Instr.
Exer- tion Title Number of of End of 4)
cisable Date Shares Month Month(1)
(Instr. 4) (Instr. 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Explanation of Responses:
David M. Knott, Knott Partners, L.P., Dorset Management Corporation, and
Matterhorn Offshore Fund Limited (the "Reporting Persons") may be deemed to have
been members of a "group" for purposes of Section 13(d) of the Exchange Act.
Each of the Reporting Persons disclaims beneficial ownership of the securities
beneficially owned by any other Reporting Person. The "group" may also have
included other persons identified in a Schedule 13D filed by Mr. Knott on July
16, 1998, and amended on October 13, 1998, November 23, 1998, December 18, 1998,
January 20, 1999, February 8, 1999 and June 30, 2000, whose transactions are not
being reported herein. Such other persons' beneficial ownership, when combined
with Mr. Knott's beneficial ownership, may have exceeded 10% of the Issuer's
outstanding common stock. The Reporting Persons disclaim beneficial ownership of
the securities beneficially owned by such other persons whose transactions are
not being reported herein.
The term of the agreement (the "Agreement") entered into among Columbia
Laboratories, Inc. (the "Company"), such other persons, Knott Partners, L.P. and
Mr. Knott, pursuant to which the Company agreed to take certain actions with
respect to the nomination of directors to the Board of Directors, the
composition of committees of the Board of Directors and certain other matters,
expired of its own terms immediately preceding the Company's 2000 Annual Meeting
of Stockholders, which was held on May 31, 2000. Accordingly, any "group"
collectively owning more than 10% of the Company's shares of which they might
previously have been deemed to be members no longer exists and the Reporting
Persons are no longer subject to Section 16 and have no Form 4 or Form 5 filing
obligations.
(1) These securities may be beneficially owned by Dorset Management Corporation.
Pursuant to Rule 13d-3 under the Exchange Act, Dorset Management Corporation may
be a beneficial owner of the shares directly owned by its clients for whom it
exercises discretionary trading authority.
(2) These securities may be beneficially owned by Mr. Knott. Pursuant to Rule
13d-3 under the Exchange Act, Mr. Knott may be a beneficial owner of all of the
securities beneficially owned by Dorset Management Corporation and Knott
Partners, L.P., as those companies sole shareholder/director and sole general
partner, respectively.
(3) Amount shown does not include shares of common stock underlying derivative
securities. Of the 778,800 shares which may be benefically owned by Mr. Knott
pursuant to Rule 13d-3 at the end of the month reported herein, Matterhorn
Offshore Fund Limited beneficially owns 108,000 of such shares; Dorset
Management Corporation may be deemed to beneficially own 420,000 of such shares;
and Knott Partners, L.P. beneficially owns 342,000 of such shares.
* Intentional misstatements or omissions of facts constitute Federal Criminal
Violations.
/s/ David M. Knott July 10, 2000
------------------------------- -----------------
**Signature of Reporting Person Date
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
Page 2 of 3 pages SEC 1474(8/92)
<PAGE>
Joint Filer Information
-----------------------
Name: Knott Partners, L.P.
Address: 485 Underhill Blvd., Suite 205
Syosset, New York 11791
Designated Filer: David M. Knott
Issuer Ticker Symbol: Columbia Laboratories, Inc. (COB)
Statement for Month/Year: June, 2000
Signature: KNOTT PARTNERS, L.P.
By: /s/ David M. Knott
-----------------------------------------
David M. Knott, General Partner
Name: Dorset Management Corporation
Address: 485 Underhill Blvd., Suite 205
Syosset, New York 11791
Designated Filer: David M. Knott
Issuer Ticker Symbol: Columbia Laboratories, Inc. (COB)
Statement for Month/Year: June, 2000
Signature: DORSET MANAGEMENT CORPORATION
By: /s/ David M. Knott
-----------------------------------------
David M. Knott, President
Name: Matterhorn Offshore Fund Limited
Address: c/o Citco Fund Service (Curacao) N.V.
Kaya Flamboyan 9
P.O. Box 707
Curacao, Netherland Antilles
Designated Filer: David M. Knott
Issuer Ticker Symbol: Columbia Laboratories, Inc. (COB)
Statement for Month/Year: June, 2000
Signature: MATTERHORN OFFSHORE FUND LIMITED
By: INTER CARRIBEAN SERVICES, LTD.
As Sole Director
By: /s/ Declan Quilligan
-----------------------------------------
Declan Quilligan
By: /s/ Clare McAdam
-----------------------------------------
Clare McAdam
